Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Impact of Azithromycin Mass Drug Administrations on All-cause Mortality and Antibiotic Resistance: Morbidity Study

NCT02048007 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02048007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02048007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Impact of Azithromycin Mass Drug Administrations on All-cause Mortality and Antibiotic Resistance: Morbidity Study
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2014
Completion date
August 27, 2020
Enrollment
72,000 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

childhood mortality